Drug reference

Anidulafungin

Echinocandin · Antifungals

Also known as Ecalta

EchinocandinAntifungals

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

Manufacturer advises avoid unless potential benefit outweighs risk —toxicity in animal studies.

FDA category + note

Mechanism

The provided textbook excerpts do not describe the specific molecular target or pathway affected by Anidulafungin's mechanism of action. However, Anidulafungin, an echinocandin, is noted to be active against Aspergillus spp. and Candida spp., leading to its clinical use for systemic candidiasis.

Indications

Invasive candidiasisCandidemia in nonneutropenic patientsCandida esophagitisAbdominal infection (Candida-related)Peritonitis (Candida-related)

Dosing

Adult: Initially 200 mg once daily for 1 day, then 100 mg once daily by intravenous infusion

Side effects

Common

Bronchospasmcholestasisdiarrhoeadyspnoeaheadachehyperglycaemiahypertensionhypokalaemiahypotensionnauseaseizureskin reactionsvomitingMinimal toxicityMinimal drug interactions

Serious